MDT
Medtronic plc
Stock
$86.38−0.06 (−0.07%)Close Oct 2, 2026
Income statement
| Line | Last 12 months | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $37.5B | $36.4B | $33.5B | $32.4B | $31.2B | $31.7B | $30.1B | $28.9B | $30.6B | $30.0B | $29.7B | $28.8B | $20.3B | $17.0B | $16.6B |
| Cost of revenue | $13.1B | $12.7B | $11.6B | $11.2B | $10.7B | $10.1B | $10.5B | $9.4B | $9.2B | $9.1B | $9.3B | $9.1B | $6.3B | $4.3B | $4.1B |
| Gross profit | $24.4B | $23.6B | $21.9B | $21.1B | $20.5B | $21.5B | $19.6B | $19.5B | $21.4B | $20.9B | $20.4B | $19.7B | $14.0B | $12.7B | $12.5B |
| R&D | $2.9B | $2.9B | $2.7B | $2.7B | $2.7B | $2.7B | $2.5B | $2.3B | $2.3B | $2.3B | $2.2B | $2.2B | $1.6B | $1.5B | $1.6B |
| SG&A | $12.2B | $11.8B | $10.8B | $10.7B | $10.4B | $10.3B | $10.1B | $10.1B | $10.4B | $10.2B | $10.0B | $9.5B | $6.9B | $5.8B | $5.7B |
| Other operating expenses | $2.5B | $2.5B | $2.4B | $2.5B | $1.9B | $2.8B | $2.5B | $2.3B | $2.4B | $1.8B | $2.8B | $2.6B | $1.6B | $1.5B | $807M |
| Operating income | $6.8B | $6.5B | $6.0B | $5.1B | $5.5B | $5.8B | $4.5B | $4.8B | $6.3B | $6.6B | $5.4B | $5.4B | $3.8B | $3.8B | $4.4B |
| Non-operating income | −$183M | −$331M | −$327M | −$307M | −$121M | −$235M | −$589M | −$736M | −$1.1B | −$965M | −$781M | −$1.0B | −$280M | −$108M | −$151M |
| Pretax income | $6.6B | $6.1B | $5.6B | $4.8B | $5.4B | $5.5B | $3.9B | $4.1B | $5.2B | $5.7B | $4.6B | $4.3B | $3.5B | $3.7B | $4.3B |
| Taxes | $1.4B | $1.3B | $966M | $1.2B | $1.6B | $478M | $289M | −$734M | $566M | $2.6B | $574M | $798M | $811M | $640M | $784M |
| Net income | $5.2B | $4.8B | $4.7B | $3.7B | $3.8B | $5.0B | $3.6B | $4.8B | $4.6B | $3.1B | $4.0B | $3.5B | $2.7B | $3.1B | $3.5B |
| Diluted EPS | $4.07 | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 | $2.66 | $3.54 | $3.41 | $2.27 | $2.89 | $2.48 | $2.41 | $3.02 | $3.37 |
| Diluted shares | — | 1.29B | 1.29B | 1.33B | 1.33B | 1.35B | 1.35B | 1.35B | 1.36B | 1.37B | 1.39B | 1.43B | 1.11B | 1.01B | 1.03B |
| Revenue growth | — | +8.4% | +3.6% | +3.6% | −1.4% | +5.2% | +4.2% | −5.4% | +2.0% | +0.8% | +3.0% | +42.3% | +19.1% | +2.5% | — |
| Gross margin | 65.0% | 65.0% | 65.3% | 65.3% | 65.7% | 68.0% | 65.2% | 67.4% | 70.0% | 69.8% | 68.7% | 68.3% | 68.9% | 74.5% | 75.1% |
| Operating margin | 18.1% | 17.8% | 17.8% | 15.9% | 17.6% | 18.2% | 14.9% | 16.6% | 20.5% | 22.2% | 18.1% | 18.6% | 18.6% | 22.4% | 26.5% |
| Net margin | 13.9% | 13.2% | 13.9% | 11.4% | 12.0% | 15.9% | 12.0% | 16.6% | 15.2% | 10.4% | 13.6% | 12.3% | 13.2% | 18.0% | 20.9% |